Literature DB >> 26401044

Replication-Competent Influenza B Reporter Viruses as Tools for Screening Antivirals and Antibodies.

Benjamin O Fulton1, Peter Palese2, Nicholas S Heaton3.   

Abstract

Influenza B virus is a human pathogen responsible for significant health and economic burden. Research into this pathogen has been limited by the lack of reporter viruses. Here we describe the development of both a replication-competent fluorescent influenza B reporter virus and bioluminescent influenza B reporter virus. Furthermore, we demonstrate these reporter viruses can be used to quickly monitor viral growth and permit the rapid screening of antiviral compounds and neutralizing antibodies.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26401044      PMCID: PMC4645317          DOI: 10.1128/JVI.02164-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus.

Authors:  Balaji Manicassamy; Santhakumar Manicassamy; Alan Belicha-Villanueva; Giuseppe Pisanelli; Bali Pulendran; Adolfo García-Sastre
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

2.  Generation of recombinant influenza virus from plasmid DNA.

Authors:  Luis Martínez-Sobrido; Adolfo García-Sastre
Journal:  J Vis Exp       Date:  2010-08-03       Impact factor: 1.355

Review 3.  Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance.

Authors:  Andrew J Burnham; Tatiana Baranovich; Elena A Govorkova
Journal:  Antiviral Res       Date:  2013-09-04       Impact factor: 5.970

Review 4.  The need for quadrivalent vaccine against seasonal influenza.

Authors:  Robert B Belshe
Journal:  Vaccine       Date:  2010-09-07       Impact factor: 3.641

Review 5.  Review of the clinical effectiveness of the neuraminidase inhibitors against influenza B viruses.

Authors:  Rubaiyea Farrukee; Jennifer Mosse; Aeron C Hurt
Journal:  Expert Rev Anti Infect Ther       Date:  2013-10-07       Impact factor: 5.091

6.  Influenza viruses with rearranged genomes as live-attenuated vaccines.

Authors:  Lindomar Pena; Troy Sutton; Ashok Chockalingam; Sachin Kumar; Matthew Angel; Hongxia Shao; Hongjun Chen; Weizhong Li; Daniel R Perez
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

7.  In vivo bioluminescent imaging of influenza a virus infection and characterization of novel cross-protective monoclonal antibodies.

Authors:  Nicholas S Heaton; Victor H Leyva-Grado; Gene S Tan; Dirk Eggink; Rong Hai; Peter Palese
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

8.  High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice.

Authors:  Jin Hee Kim; Sang-Rok Lee; Li-Hua Li; Hye-Jeong Park; Jeong-Hoh Park; Kwang Youl Lee; Myeong-Kyu Kim; Boo Ahn Shin; Seok-Yong Choi
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

9.  Visualizing influenza virus infection in living mice.

Authors:  Weiqi Pan; Zhenyuan Dong; Feng Li; Weixu Meng; Liqiang Feng; Xuefeng Niu; Chufang Li; Qinfang Luo; Zhengfeng Li; Caijun Sun; Ling Chen
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  A bright monomeric green fluorescent protein derived from Branchiostoma lanceolatum.

Authors:  Nathan C Shaner; Gerard G Lambert; Andrew Chammas; Yuhui Ni; Paula J Cranfill; Michelle A Baird; Brittney R Sell; John R Allen; Richard N Day; Maria Israelsson; Michael W Davidson; Jiwu Wang
Journal:  Nat Methods       Date:  2013-03-24       Impact factor: 28.547

View more
  8 in total

1.  Directed Evolution of an Influenza Reporter Virus To Restore Replication and Virulence and Enhance Noninvasive Bioluminescence Imaging in Mice.

Authors:  Hui Cai; Meisui Liu; Charles J Russell
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

Review 2.  Reverse genetics for influenza B viruses and recent advances in vaccine development.

Authors:  Stivalis Cardenas-Garcia; C Joaquin Caceres; Daniela Rajao; Daniel R Perez
Journal:  Curr Opin Virol       Date:  2020-11-27       Impact factor: 7.090

Review 3.  Fluorescent and Bioluminescent Reporter Myxoviruses.

Authors:  Christina A Rostad; Michael C Currier; Martin L Moore
Journal:  Viruses       Date:  2016-08-04       Impact factor: 5.048

Review 4.  The Development and Use of Reporter Influenza B Viruses.

Authors:  Rebekah E Dumm; Nicholas S Heaton
Journal:  Viruses       Date:  2019-08-09       Impact factor: 5.048

5.  Non-lytic clearance of influenza B virus from infected cells preserves epithelial barrier function.

Authors:  Rebekah E Dumm; Jessica K Fiege; Barbara M Waring; Chay T Kuo; Ryan A Langlois; Nicholas S Heaton
Journal:  Nat Commun       Date:  2019-02-15       Impact factor: 14.919

6.  Influenza B Virus Infection Is Enhanced Upon Heterotypic Co-infection With Influenza A Virus.

Authors:  Nicolas Malausse; Sylvie van der Werf; Nadia Naffakh; Sandie Munier
Journal:  Front Microbiol       Date:  2021-02-25       Impact factor: 5.640

7.  Development of Robust Varicella Zoster Virus Luciferase Reporter Viruses for In Vivo Monitoring of Virus Growth and Its Antiviral Inhibition in Culture, Skin, and Humanized Mice.

Authors:  Megan G Lloyd; Michael B Yee; Joseph S Flot; Dongmei Liu; Brittany W Geiler; Paul R Kinchington; Jennifer F Moffat
Journal:  Viruses       Date:  2022-04-15       Impact factor: 5.818

8.  Replication-Competent Influenza A and B Viruses Expressing a Fluorescent Dynamic Timer Protein for In Vitro and In Vivo Studies.

Authors:  Michael Breen; Aitor Nogales; Steven F Baker; Daniel R Perez; Luis Martínez-Sobrido
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.